Search research articles
Contact Us
Filters
Showing results (91-100 of 170) with videos related to
Page
of 17
Sort By:
Rheumatology (Oxford, England)
|
October 21, 2024
Infliximab vs interferon-α in the treatment of Behçet's syndrome: clinical data from the BIO-BEHÇET'S randomized controlled trial
Robert J Moots, Farida Fortune, Richard Jackson, et al.
Inflammatory Bowel Diseases
|
June 1, 2016
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use
Sreedhar Subramanian, Rebecca Asher, William Weston, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
December 15, 2020
Reply to Mathew
Hayley Fowler, Rachael E Clifford, Paul Sutton, et al.
Environmental Science & Technology
|
January 10, 2017
Bioavailability and Kidney Responses to Diclofenac in the Fathead Minnow (Pimephales promelas)
Lisa K Bickley, Ronny van Aerle, A Ross Brown, et al.
The Journal of Clinical Psychiatry
|
November 30, 2022
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia
Richard Jackson, Matthew N Brams, Noelle E Carlozzi, et al.
International Journal of Cancer
|
March 5, 2013
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
Michael Thornton, Mohammed A Aslam, Elizabeth M Tweedle, et al.
Pilot and Feasibility Studies
|
June 9, 2020
Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): study protocol for a randomised external pilot trial
Mandeep S Bajwa, Stacey Carruthers, Rob Hanson, et al.
Diabetes Care
|
September 11, 2009
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
Tihamer Orban, Jay M Sosenko, David Cuthbertson, et al.
Nutrients
|
December 11, 2025
Point-of-Care Testing in PKU: A New ERA of Blood Phenylalanine Monitoring
Alex Pinto, Adam Gerrard, Suresh Vijay, et al.
Rheumatology and Immunology Research
|
July 3, 2025
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trial
Robert J Moots, Farida Fortune, Richard Jackson, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 170) with videos related to
Sort By:
Page
of 17
Rheumatology (Oxford, England)
|
October 21, 2024
Infliximab vs interferon-α in the treatment of Behçet's syndrome: clinical data from the BIO-BEHÇET'S randomized controlled trial
Robert J Moots, Farida Fortune, Richard Jackson, et al.
Inflammatory Bowel Diseases
|
June 1, 2016
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use
Sreedhar Subramanian, Rebecca Asher, William Weston, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
December 15, 2020
Reply to Mathew
Hayley Fowler, Rachael E Clifford, Paul Sutton, et al.
Environmental Science & Technology
|
January 10, 2017
Bioavailability and Kidney Responses to Diclofenac in the Fathead Minnow (Pimephales promelas)
Lisa K Bickley, Ronny van Aerle, A Ross Brown, et al.
The Journal of Clinical Psychiatry
|
November 30, 2022
Impact-Tardive Dyskinesia (Impact-TD) Scale: A Clinical Tool to Assess the Impact of Tardive Dyskinesia
Richard Jackson, Matthew N Brams, Noelle E Carlozzi, et al.
International Journal of Cancer
|
March 5, 2013
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
Michael Thornton, Mohammed A Aslam, Elizabeth M Tweedle, et al.
Pilot and Feasibility Studies
|
June 9, 2020
Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): study protocol for a randomised external pilot trial
Mandeep S Bajwa, Stacey Carruthers, Rob Hanson, et al.
Diabetes Care
|
September 11, 2009
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
Tihamer Orban, Jay M Sosenko, David Cuthbertson, et al.
Nutrients
|
December 11, 2025
Point-of-Care Testing in PKU: A New ERA of Blood Phenylalanine Monitoring
Alex Pinto, Adam Gerrard, Suresh Vijay, et al.
Rheumatology and Immunology Research
|
July 3, 2025
Predicting response to infliximab and interferon-α in Behçet's syndrome: An exploratory analysis from the BIO-BEHÇET'S randomized controlled trial
Robert J Moots, Farida Fortune, Richard Jackson, et al.
Page
of 17